Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
molibresib (GSK525762)
i
Other names:
GSK525762, GSK525762C, 525762, GSK 525762, GSK525762A, IBET762, I-BET-762, I-BET762, GSK-525762, GSK-525762A, GSK 525762A
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
GSK
Drug class:
BET inhibitor
Related drugs:
‹
JQ-1 (27)
ABBV-744 (7)
ZEN-3694 (6)
INCB057643 (4)
BI 894999 (4)
ABBV 075 (3)
GS-626510 (2)
PLX51107 (2)
DAK539 (2)
CPI-203 (1)
RG6146 (1)
ARCC-29 (0)
BET inhibitor (0)
CA2 (0)
CC-95775 (0)
EP31670 (0)
GSK1324726A (0)
INCB054329 (0)
JAB-8263 (0)
NHWD-870 (0)
ODM-207 (0)
OPN-2853 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
ZEN-3219 (0)
ZEN003365 (0)
GS-5829 (0)
BMS-986158 (0)
BMS-986378 (0)
JQ-1 (27)
ABBV-744 (7)
ZEN-3694 (6)
INCB057643 (4)
BI 894999 (4)
ABBV 075 (3)
GS-626510 (2)
PLX51107 (2)
DAK539 (2)
CPI-203 (1)
RG6146 (1)
ARCC-29 (0)
BET inhibitor (0)
CA2 (0)
CC-95775 (0)
EP31670 (0)
GSK1324726A (0)
INCB054329 (0)
JAB-8263 (0)
NHWD-870 (0)
ODM-207 (0)
OPN-2853 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
ZEN-3219 (0)
ZEN003365 (0)
GS-5829 (0)
BMS-986158 (0)
BMS-986378 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
GSK525762
Sensitive: C3 – Early Trials
GSK525762
Sensitive
:
C3
GSK525762
Sensitive: C3 – Early Trials
GSK525762
Sensitive
:
C3
MYC amplification
Small Cell Lung Cancer
MYC amplification
Small Cell Lung Cancer
talazoparib + GSK525762
Sensitive: D – Preclinical
talazoparib + GSK525762
Sensitive
:
D
talazoparib + GSK525762
Sensitive: D – Preclinical
talazoparib + GSK525762
Sensitive
:
D
ZNF765 overexpression
Hepatocellular Cancer
ZNF765 overexpression
Hepatocellular Cancer
GSK525762
Sensitive: D – Preclinical
GSK525762
Sensitive
:
D
GSK525762
Sensitive: D – Preclinical
GSK525762
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.